Search clinical trials for: Negative hormone-receptor status

Total 9077 results

Institut de cancérologie Strasbourg Europe
Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Recruiting

Prediction of Radiotherapy Efficacy in Patients With Triple-negative Breast Cancer (TNBC-RT2023)

Triple-negative Breast Cancer

France
Jilin University

Recruiting

White Light Endoscopy and Magnifying Endoscopy in Assessing the Status of Hp Infection

Helicobacter Pylori Infection

China
FengYan Jin

Not yet recruiting

A Perspective, Single Center Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persistent Minimal Residual Disease After Initial Treatment (MRD)

Multiple Myeloma | Minimal Residual Disease
Hongmei Zheng

Recruiting

The Benefits of Continued Use of Ovarian Function Suppression After 5 Years

Endocrine Therapy | Breast Cancer Female

China
Centre Antoine Lacassagne

Recruiting

Study to Determine the Safety and Efficacy of Ribociclib in Combination With Hormone Therapy and Hypofractionated Radiotherapy in Breast Cancer, With Positive Hormone Receptors and Negative HER2 Status, in Newly Diagnosed, Not Immediately Operable Elderly Patient (CALHYS) (CALHYS)

HER2 Negative Breast Cancer Not Immediately Operated

France
Emory University
National Cancer Institute (NCI)

Recruiting

Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Hormone Receptor-Positive Breast Carcinoma | HER2-Negative Breast Carcinoma

United States
Pennington Biomedical Research Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Low Oxygen Exposure and Weight Status (LOWS)

Obesity

United States
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Evaluation of Long-term Health Status and Quality of Life in Adult Survivors With Philadelphia-negative Acute Lymphoblastic Leukemia/Lymphoma Treated With an Intensive Pediatric or Pediatric-inspired Protocol (EQUAALL01)

Acute Lymphoblastic Leukemia | Acute Lymphoblastic Lymphoma
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

More Than 50% of the Patients With Clinically Unifocal T1b/Small T2 Node Negative Papillary Thyroid Carcinoma Scheduled for Thyroid Lobectomy May Require Completion Thyroidectomy if the Nodal Status is Evaluated (cN0PTC)

Thyroid Cancer, Papillary | Thyroid Carcinoma | Thyroid Cancer | Papillary Thyroid Cancer | Lymph Node Metastasis | Papillary Carcinoma
Universidade Federal do Amazonas

Completed

Effects of the Use of Probiotics on the Intestinal Microbiota of Patients With Gastric Cancer (PRONIC-G)

Gastric Cancer | Nutritional Status | Gastric Adenocarcinoma | Cytokines | Microbiome

Brazil
Pfizer
AstraZeneca

Completed

Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)

Metastatic Breast Cancer

Korea, Republic of, United States, Canada, United Kingdom, Australia, Taiwan, Netherlands, Italy, Japan, Belgium, Ireland, Ukraine, Portugal, Germany, Romania, Russian Federation, Turkey
National Cancer Center, Japan
Pfizer; Korean Cancer Study Group

Active, not recruiting

PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY (PATHWAY)

Breast Neoplasms

Korea, Republic of, Singapore, Japan, Taiwan
M.D. Anderson Cancer Center

Active, not recruiting

Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditions

United States
Memorial Sloan Kettering Cancer Center
Cedars-Sinai Medical Center

Completed

Homologous Recombination Repair Status as a Biomarker of Response in Locally Recurrent/Metastatic Triple Negative Breast Cancer Patients Treated With Concurrent Cisplatin and Radiation Therapy

Locally Recurrent/Metastatic Triple Negative Breast Cancer

United States
Central Hospital, Nancy, France

Completed

Influenza and Pertussis Vaccination Status of Women in Immediate Postpartum and Caregivers (COVAGRIP)

Influenza Viral Infections | Pertussis/Whooping Cough

France
UNICANCER
ARCAGY/ GINECO GROUP; SOLTI Breast Cancer Research Group

Active, not recruiting

Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients. (DOLAF)

ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer | a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status

France
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer

Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IIIC Breast Cancer | HER2/Neu Negative | Stage III Breast Cancer | Postmenopausal | Estrogen Receptor Status

United States
University of Alabama at Birmingham
Novartis Pharmaceuticals; Tracon Pharmaceuticals Inc.

Completed

Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer

Breast Cancer

United States
MedSIR
AstraZeneca; Daiichi Sankyo, Inc.

Completed

Real-World Data of Clinicopathological Characteristics and Management of Breast Cancer Patients According to HER2 Status (RosHER)

Metastatic Breast Cancer | Early Breast Cancer | Locally Advanced Breast Cancer

Spain
AstraZeneca
British Columbia Cancer Agency

Completed

Phase II Study of AZD2281 in Patients With Known BRCA Mutation Status or Recurrent High Grade Ovarian Cancer or Patients With Known BRCA Mutation Status/ Triple Neg Breast Cancer

Breast Cancer | Ovarian Carcinoma

Canada
AstraZeneca
Daiichi Sankyo, Inc.

Completed

Estimation of the Prevalence of HER2 Low and Describe the SoC, Treatment Patterns, and Outcome in Real-world Practice Among Unresectable and/or Metastatic Breast Cancer Patients With HER2 Low Status

Breast Cancer

United States, Germany, Italy, Korea, Republic of, United Kingdom, Portugal, Australia, Japan, Canada, France
Gérond'if

Completed

Personalized Dietary Advice 3 Months After Discharge From Hospitalization in Geriatrics: Effect on Nutritional Status According to Coronavirus Disease 2019 (COVID-19) Status (Positive or Negative) During Hospitalization (COVINUT)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

France
Florida State University

Withdrawn

Daily Low Oxygen Exposure and Weight Status (LOWS)

Overweight and Obesity

United States
Georgetown University
University of Chicago; Thomas Jefferson University

Completed

Palbociclib / Letrozole or Fulvestrant in African American Women With HR+ HER2- Breast Cancer (PALINA)

Hormone Receptor Positive HER-2 Negative Breast Cancer

United States
Novartis Pharmaceuticals

Completed

Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer. (LeeBLet)

Advanced or Metastatic Breast Cancer

Spain, United States
Assiut University

Unknown

The Status of Helicobacter Pylori Infection Among Children Visiting Assiut Children Hospital

Helicobacter Pylori Infection
University Hospital, Grenoble

Unknown

Predictive Value of PET CT in the Histologic Lymph Node Status of Patients With Squamous Cell Carcinoma of the Oral N0 Clinical and Radiological Cavity. (ORNICA)

Squamous Cell Carcinoma of the Oral | Clinically Node-Negative and Radiology

France
Asan Medical Center

Completed

Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer (LEO)

Metastatic Breast Cancer

Korea, Republic of
Université Catholique de Louvain
Anticancer Fund, Belgium

Completed

Ketorolac in Breast Cancer Surgery (KBCt)

Curative Breast Cancer Surgery | Inflammatory Positive/Negative Status | Pre Surgical Incision Administration

Belgium
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Terminated

Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

Breast Cancer

United States
Eisai Co., Ltd.

Completed

Post-Marketing Surveillance Study of Eribulin on the Status and Factors for the Development of Peripheral Neuropathy in Japan.

Breast Cancer | HER2-negative Breast Cancer

Japan
FrieslandCampina WAMCO Nigeria PLC
Lagos State University

Unknown

The Effect of Fortified Growing-up Milk on Growth and Micronutrient Status of Nigerian Toddlers (GaGA)

Enterobacteriaceae Infections | Nutritional Deficiency | Iron-deficiency Anemia | Nutritional Stunting | Nutritional Wasting | Malnutrition; Mild
Weill Medical College of Cornell University

Completed

Anti-Pseudomonas Immune Status and Dendritic Cell Preparation in Normal Individuals

Healthy
Mayo Clinic
National Cancer Institute (NCI)

Completed

Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue

Molecular Imaging

United States
Bristol-Myers Squibb
US Oncology Research

Completed

Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic

Metastatic Breast Cancer

United States
Dana-Farber Cancer Institute
Novartis; Beth Israel Deaconess Medical Center

Completed

Extended Endocrine Therapy for Premenopausal Women With Breast Cancer

Breast Cancer

United States
Jules Bordet Institute

Withdrawn

TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free Regimen (TRIUMPH)

Breast Cancer

Belgium
Vejle Hospital
Abbott

Completed

Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status

Ovarian Cancer

Denmark
Butler Hospital
National Institute on Drug Abuse (NIDA)

Completed

A Trial to Reduce Hepatitis C Among Injection Drug Users - 1

HCV Negative Status | HCV Risk Behavior

United States
Thomas Jefferson University

Unknown

Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer

Breast Cancer

United States
University Hospital Freiburg
Roche Pharma AG; Genzyme, a Sanofi Company; Astellas Pharma GmbH

Completed

Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation (Harmony)

Disorder Related to Renal Transplantation

Germany
National Institute of Diabetes and Digestive and...
National Center for Research Resources (NCRR)

Completed

Benefits and Risks of Newborn Screening for Cystic Fibrosis

Cystic Fibrosis | Lung Disease | Pseudomonas Infections

United States
Northwell Health
Pfizer; Stanley Medical Research Institute; Janssen Pharmaceutica N.V., Belgium

Completed

Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms

Psychotic Disorders | Prodromal Schizophrenia

United States
Angiex, Inc.

Recruiting

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Cancer | Pancreatic Adenocarcinoma | Triple Negative Breast Cancer | Metastatic Solid Tumor | Advanced Cancer | Pancreas Cancer | Locally Advanced Carcinoma

United States
The First Affiliated Hospital of Guangzhou Medical...

Recruiting

The Effect of Different Body Positions and Channel Sheaths on RIRS

Urolithiasis

China
MedMira Laboratories Inc.

Not yet recruiting

Cross-sectional Investigational Study to Evaluate the Sensitivity, Specificity, and Utility of the MedMira Inc. Multiplo® Complete Syphilis (TP/nTP) Antibody Test (POCT) to Diagnose Infectious Syphilis in Participants Attending the Sexual Health Clinic in Ottawa, Ontario.

Treponema Pallidum

Canada
Roswell Park Cancer Institute

Not yet recruiting

Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Unresectable Triple-Negative Breast Carcinoma

United States
Beijing GoBroad Hospital

Not yet recruiting

Study of ADCs Combined With Adebrelimab in HER2-negative Advanced Breast Cancer

Advanced Breast Cancer

China
Postgraduate Institute of Dental Sciences Rohtak

Not yet recruiting

Impact of Subgingival Instrumentation on Psychological Distress and Mental Health Status in Bruxers With Periodontitis

Periodontitis | Periodontal Diseases | Bruxism | Distress, Emotional

India
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy

Breast Cancer | Triple Negative Breast Cancer

United States

Search clinical trials for: Negative hormone-receptor status

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations